SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (364)5/26/1999 7:52:00 PM
From: scaram(o)uche  Respond to of 579
 
Lilly
will conduct and fund all clinical trials for compounds discovered during the project and will receive an exclusive option to
SIBIA's two clinical candidates

You're correct. The "clinical trial funding" language doesn't relate to the option. Thanks.



To: LLCF who wrote (364)5/26/1999 7:59:00 PM
From: scaram(o)uche  Respond to of 579
 
>> CANT BELIEVE THE STOCK CLOSED WHERE IT DID! <<

Maybe it was Lilly Capital Management, shorting into demand.

Don't forget, we've got Saks, von Emster, TSC and others betting against us. Summer is coming, and they want this year to be like last year. Sobering.

OTOH, I think the word is getting out loud and clear that small cap biotech is cheap, if you find the good science.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News